Unravel the tumor microenvironment on a multiomic level to develop a more holistic picture of cancer
Investigate DNA variants, analyze differential gene expression, profile the immune repertoire and study the tumor microbiome with dedicated NGS technologies
Detect and analyze relevant biomarkers – from sample preparation to NGS and dPCR analysis and data interpretation
•Discover and validate biomarkers for all liquid biopsy approaches: Circulating cell-free nucleic acids, CTCs and exosomes
Identify clinically relevant mutations in critical cancer genes to support precision medicine
Access IVD solutions with multiple analytes and technologies, providing true flexibility in tailoring CDx programs